CJC-1295 (with DAC)
UnapprovedResearch compound
Rs. 6,999.00
Best available evidence
in vitro
preclinical
human pilot
human trial
CJC-1295 (with DAC) is a synthetic GHRH analogue carrying a Drug Affinity Complex (DAC) modification. Veracyl supplies it as a reference compound for in vitro and laboratory research only.
Research use only. Not for human or veterinary use. Not a drug, supplement, or food. Not evaluated by any regulatory authority. No dosing or administration guidance is provided.
Certificate of Analysis
COA pending upload for this batch
COA pending upload for this batch
Research use only
This compound is supplied strictly for in vitro and laboratory research use. It is not for human or veterinary use, not a drug, supplement, or food, and has not been evaluated by any regulatory authority for safety or efficacy. No dosing, administration, or therapeutic guidance is provided.
Evidence stagePreclinical
RegulatoryUnapproved